Epidemiology of community-acquired bacterial meningitis
- 1 February 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Infectious Diseases
- Vol. 31 (1), 78-84
- https://doi.org/10.1097/qco.0000000000000417
Abstract
The epidemiology of bacterial meningitis has been dynamic in the past 30 years following introduction of conjugated vaccines against Haemophilus influenzae type B, Streptococcus pneumoniae and Neisseria meningitidis. The purpose of this review is to describe recent developments in bacterial meningitis epidemiology. The incidence of bacterial meningitis in Western countries (Finland, Netherlands, and the United States) gradually declined by 3–4% per year to 0.7–0.9 per 100 000 per year in the past 10–20 years. In African countries (Burkina Faso and Malawi), incidence rates are still substantially higher at 10–40 per 100 000 persons per year. Introduction of pneumococcal conjugate vaccines have not consistently decreased overall pneumococcal meningitis incidence because of serotype replacement. Following the introduction of serogroup A and C meningococcal vaccines, the incidence of meningococcal meningitis because of these serogroups strongly decreased. Novel outbreaks in the African meningitis belt by serogroup C and increased incidence of serogroup W in the United Kingdom and the Netherlands were observed recently. Bacterial meningitis remains an important infectious disease, despite a gradual decline in incidence after large-scale vaccination campaigns. Further development of vaccines with broader coverage is important, as is continuous surveillance of bacterial meningitis cases.Keywords
This publication has 61 references indexed in Scilit:
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in AfricansNew England Journal of Medicine, 2011
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype ProjectPLoS Medicine, 2010
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial MeningitisClinical Microbiology Reviews, 2010
- Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal DiseaseThe Pediatric Infectious Disease Journal, 2008
- Clinical Features, Outcome, and Meningococcal Genotype in 258 Adults With Meningococcal MeningitisMedicine, 2008
- Community-acquired Haemophilus influenzae meningitis in adultsClinical Microbiology & Infection, 2007
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006
- Clinical Features and Prognostic Factors in Adults with Bacterial MeningitisNew England Journal of Medicine, 2004
- Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum ChemoprophylaxisNew England Journal of Medicine, 1986